CD274 and neoplasm: The tumor cells produce large amounts of IDO and activating cytokines, such as IFNs, IL-12, and IL-23, while over-expressing PD-L1-driven inhibitory signals, down-regulating MHC class I molecules and activating alternative pathways that weaken anti-cancer immunity (97).